The Centers for Medicare & Medicaid Services (CMS) has issued a Quality & Safety Memo providing guidance for Clinical Laboratory Improvement Amendments (CLIA) laboratories during the COVID-19 pandemic. The memo allows pathologists to review pathology slides remotely under certain conditions, expedites the review of CLIA applications, and highlights that laboratories within a hospital or university campus may hold a single certificate for laboratory sites within the same location. The memo also offers enforcement discretion for Proficiency Testing during the public health emergency, addresses alternate specimen collection devices, and provides guidance on Laboratory Developed Tests. The memo is only applicable during the COVID-19 public health emergency and laboratories must continue to follow any state laws governing laboratories.
Summaries are generataed using AI. Check important information.
Change preference
